The discovery and development of HMG-CoA reductase inhibitors.

Regulation of the mevalonate pathway

Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906

All ras proteins are polyisoprenylated but only some are palmitoylated

Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,775

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

Alberts, A. W., Chen, J., Kuron, G. W., Hunt, V. M., Huff, J. W., Hoffman, C., Rothrock, J. W., López, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,630

Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease.

(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-786_2 · Cited by 1,426

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

Endo, A., KURODA, M., & Tsujita, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954

Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity

Endo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 800

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760

Influence of nicotinic acid on serum cholesterol in man

Altschul, R., Hoffer, A., & Stephen, J. D. (1955) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(55)90070-9 · Cited by 726

Triglycerides and cardiovascular disease

Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419

The role of natural product chemistry in drug discovery

Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology

Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116

Natural products to drugs: natural product-derived compounds in clinical trials

Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,086

A Tale of Coronary Artery Disease and Myocardial Infarction

Nabel, E. G., & Braunwald, E. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1112570 · Cited by 1,024

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts

Aulchenko, Y. S., Janssens, A. C. J. W., Albert Hofman, D., Isaacs, A. J., Sijbrands, E. J. G., Witteman, J. C. M., van Duijn, C. M., Ripatti, S., Lindqvist, I., Perola, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.269 · Cited by 860

An analysis of FDA-approved drugs: natural products and their derivatives

Patridge, E. V., Gareiss, P. C., Kinch, M. S., & Hoyer, D. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.009 · Cited by 860

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813

New insights into the pharmacodynamic and pharmacokinetic properties of statins

Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug–drug interactions and interindividual differences in transporter and metabolic enzyme functions

Shitara, Y., & Sugiyama, Y. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.03.003 · Cited by 583

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

Bateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573

A historical perspective on the discovery of statins

Endo, A. (2010) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.86.484 · Cited by 550

Natural products to drugs: natural product derived compounds in clinical trials

Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 496

Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor

Nawrocki, J. W., Weiss, S. R., Davidson, M. H., Sprecher, D. L., Schwartz, S. L., Lupien, P.-J., Jones, P. H., Haber, H. E., & Black, D. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.5.678 · Cited by 484

Rumen methanogens and mitigation of methane emission by anti-methanogenic compounds and substances

Patra, A. K., Park, T., Kim, M., & Yu, Z. (2017) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-017-0145-9 · Cited by 513

Dysregulation of the mevalonate pathway promotes transformation

Clendening, J. W., Pandyra, A., Boutros, P. C., Ghamrasni, S. E., Khosravi, F., Trentin, G. A., Martirosyan, A., Hakem, A., Hakem, R., Jurišica, I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910258107 · Cited by 416

Gut microbiota and cardiovascular disease: opportunities and challenges

Kazemian, N., Mahmoudi, M., Halperin, F. A., Wu, J. C., & Pakpour, S. (2020) · Microbiome · doi:10.1186/s40168-020-00821-0 · Cited by 404

Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport

Jia, L., Betters, J. L., & Yu, L. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142233 · Cited by 356

Bioactive Compounds from Marine Bacteria and Fungi

Debbab, A., Aly, A. H., Lin, W. H., & Proksch, P. (2010) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00179.x · Cited by 366

Cardiac cachexia: A systematic overview

von Haehling, S., Lainščak, M., Springer, J., & Anker, S. D. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.009 · Cited by 356

Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine

Brusq, J.-M. G., Ancellin, N., Grondin, P., Guillard, R., Martin, S., Saintillan, Y., & Issandou, M. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600020-jlr200 · Cited by 344

Non-lipid-related effects of statins

Bellosta, S., Fed, N., Bernini, F., Paoletti, R., & Corsini, A. (2000) · Annals of Medicine · doi:10.3109/07853890008998823 · Cited by 338

Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies

Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331

A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous system

Bateman, R. J., Siemers, E. R., Mawuenyega, K. G., Wen, G., Browning, K. R., Sigurdson, W. C., Yarasheski, K. E., Friedrich, S. W., DeMattos, R. B., May, P. C., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21623 · Cited by 322

Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation

Parihar, S. P., Guler, R., Khutlang, R., Lang, D. M., Hurdayal, R., Mhlanga, M. M., Suzuki, H., Marais, A. D., & Brombacher, F. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit550 · Cited by 320

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 345

Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats

Babu, P. S., & Srinivasan, K. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006819605211 · Cited by 282

Pharmacology of competitive inhibitors of HMg-CoA reductase

Corsini, A. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)80042-5 · Cited by 275

Brain cholesterol turnover required for geranylgeraniol production and learning in mice

Kotti, T. J., Ramirez, D. M. O., Pfeiffer, B. E., Huber, K. M., & Russell, D. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600316103 · Cited by 270

Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells

Cafforio, P., Dammacco, F., Gernone, A., & Silvestris, F. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi036 · Cited by 250

The role of the LDL receptor in apolipoprotein B secretion

Twisk, J., Gillian‐Daniel, D. L., Oler, A. T., Wang, L., Barrett, P. H. R., & Attie, A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8623 · Cited by 245

Targeting tumor cell metabolism with statins

Clendening, J. W., & Penn, L. Z. (2012) · Oncogene · doi:10.1038/onc.2012.6 · Cited by 247

Comprehensive LC−MSE Lipidomic Analysis using a Shotgun Approach and Its Application to Biomarker Detection and Identification in Osteoarthritis Patients

Castro‐Perez, J. M., Kamphorst, J. J., DeGroot, J., Lafeber, F. P. J. G., Goshawk, J., Yu, K., Shockcor, J. P., Vreeken, R. J., & Hankemeier, T. (2010) · Journal of Proteome Research · doi:10.1021/pr901094j · Cited by 238

HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.

Soma, M. R., Donetti, E., Parolini, C., Mazzini, G., Ferrari, C., Fumagalli, R., & Paoletti, R. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.4.571 · Cited by 225

Clinical Pharmacokinetics of Pravastatin

Hatanaka, T. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039060-00002 · Cited by 225

Direct vascular effects of HMG-CoA reductase inhibitors

Bellosta, S., Bernini, F., Ferri, N., Quarato, P., Canavesi, M., Arnaboldi, L., Fumagalli, R., Paoletti, R., & Corsini, A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00319-5 · Cited by 224

NPC1L1 and cholesterol transport

Betters, J. L., & Yu, L. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.030 · Cited by 213

Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials

Zheng, X., Xu, Y.-L., Li, S., Liu, X., Hui, R., & Huang, X. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.010926 · Cited by 215

Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial

Bjarnadottir, O., Romero, Q., Bendahl, P.-O., Jirström, K., Rydén, L., Loman, N., Uhlén, M., Johannesson, H., Rose, C., Grabau, D., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2473-6 · Cited by 230

Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy

Steinberg, D. H. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600009-jlr200 · Cited by 205

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase

Blum, C. B. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90626-2 · Cited by 192

Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1–40) and (1–42) peptides

Arispe, N. J., & Doh, M. (2002) · The FASEB Journal · doi:10.1096/fj.02-0829com · Cited by 192

Statins Reduce Amyloid-β Production through Inhibition of Protein Isoprenylation

Ostrowski, S. M., Wilkinson, B. L., Golde, T. E., & Landreth, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702640200 · Cited by 180

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate β-Amyloid-Induced Microglial Inflammatory Responses

Cordle, A. C., & Landreth, G. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2544-04.2005 · Cited by 177

Preventing Coronary Artery Disease by Lowering Cholesterol Levels

Steinberg, D. H., & Gotto, A. M. (1999) · JAMA · doi:10.1001/jama.282.21.2043 · Cited by 178

The diabetogenic action of statins — mechanisms and clinical implications

Betteridge, D. J., & Carmena, R. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.194 · Cited by 176

Mining the Metabiome: Identifying Novel Natural Products from Microbial Communities

Milshteyn, A., Schneider, J. S., & Brady, S. F. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.006 · Cited by 177

Clinical Pharmacokinetics of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors

Desager, J., & Horsmans, Y. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631050-00003 · Cited by 167

The Effect of Statins on mRNA Levels of Genes Related to Inflammation, Coagulation, and Vascular Constriction in HUVEC.

Morikawa, S., Takabe, W., Mataki, C., Kanke, T., Itoh, T., Wada, Y., Izumi, A., Saitō, Y., Hamakubo, T., & Kodama, T. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.178 · Cited by 167

Red Wine Polyphenolics Increase LDL Receptor Expression and Activity and Suppress the Secretion of ApoB100 from Human HepG2 Cells

Pal, S., Ho, N., Santos, C., Dubois, P., Mamo, J. C. L., Allister, E. M., & Croft, K. D. (2003) · Journal of Nutrition · doi:10.1093/jn/133.3.700 · Cited by 165

Cholesterol and beyond - The role of the mevalonate pathway in cancer biology

Göbel, A., Rauner, M., Hofbauer, L. C., & Rachner, T. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188351 · Cited by 175

Human cholesterol metabolism and therapeutic molecules

Charlton-Menys, V., & Durrington, P. N. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2007.035147 · Cited by 167

Emerging roles of the intestine in control of cholesterol metabolism

Kruit, J. K. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i40.6429 · Cited by 165

Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage

Chaichana, K. L., Pradilla, G., Huang, J., & Tamargo, R. J. (2009) · World Neurosurgery · doi:10.1016/j.surneu.2009.05.027 · Cited by 157

A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer

Han, J., Lee, S.-H., Yoo, N. J., Hyung, L. S., Moon, Y. J., Yun, T., Kim, H. T., & Lee, J. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2525 · Cited by 159

A gift from nature: the birth of the statins

Endo, A. (2008) · Nature Medicine · doi:10.1038/nm1008-1050 · Cited by 152

Chronic Cholesterol Depletion Using Statin Impairs the Function and Dynamics of Human Serotonin1A Receptors

Shrivastava, S. K., Pucadyil, T. J., Paila, Y. D., Ganguly, S., & Chattopadhyay, A. (2010) · Biochemistry · doi:10.1021/bi100276b · Cited by 154

A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit

Bursill, C. A., Abbey, M., & Roach, P. D. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.033 · Cited by 149

Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer’s disease

Jeong, A., Suazo, K. F., Wood, W. G., Distefano, M. D., & Li, L. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1458070 · Cited by 152

The role of ATP citrate-lyase in the metabolic regulation of plasma lipids

PEARCE, N. J., Yates, J. W., Berkhout, T. A., Jackson, B., Tew, D. G., Boyd, H., Camilleri, P., Sweeney, P. J., Gribble, A. D., Shaw, A. N., et al. (1998) · Biochemical Journal · doi:10.1042/bj3340113 · Cited by 144

Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis

Ndlovu, H., & Marakalala, M. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00434 · Cited by 142

Policosanol Modulates HMG-CoA Reductase Activity in Cultured Fibroblasts

Menéndez, R. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(00)00265-4 · Cited by 135

Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters.

Cho, I.-J., Ahn, J., Kim, S., Choi, M.-S., & Ha, T. (2008) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2007.12.140 · Cited by 130

Cholesterol-Lowering Activity of Naringenin via Inhibition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Acyl Coenzyme A:Cholesterol Acyltransferase in Rats

Lee, S., Park, Y. B., Bae, K., Bok, S., Kwon, Y., Lee, E. S., & Choi, M. (1999) · Annals of Nutrition and Metabolism · doi:10.1159/000012783 · Cited by 128

SOAT1 promotes mevalonate pathway dependency in pancreatic cancer

Oni, T. E., Biffi, G., Baker, L. A., Yuan, H., Tonelli, C., Somerville, T. D. D., Deschênes, A., Belleau, P., Hwang, C., Rivera, F. J. S., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192389 · Cited by 126

Animal Models of Atherosclerosis–Supportive Notes and Tricks of the Trade

Gisterå, A., Ketelhuth, D. F. J., Malin, S., & Hansson, G. K. (2022) · Circulation Research · doi:10.1161/circresaha.122.320263 · Cited by 127

Prenylation-dependent Association of Ki-Ras with Microtubules

Thissen, J., Gross, J. M., Subramanian, K., Meyer, T., & Casey, P. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30362 · Cited by 117

Decanolides, 10-membered lactones of natural origin

Dräger, G., Kirschning, A., Thiericke, R., & Zerlin, M. (1996) · Natural Product Reports · doi:10.1039/np9961300365 · Cited by 115

Hypocholesterolemic and antioxidative effects of naringenin and its two metabolites in high-cholesterol fed rats

Jeon, S.-M., Kim, H., Kim, H.-J., Do, G., Jeong, T., Park, Y. B., & Choi, M. (2006) · Translational research · doi:10.1016/j.trsl.2006.08.001 · Cited by 112

Lupin Peptides Lower Low-Density Lipoprotein (LDL) Cholesterol through an Up-regulation of the LDL Receptor/Sterol Regulatory Element Binding Protein 2 (SREBP2) Pathway at HepG2 Cell Line

Lammi, C., Zanoni, C., Scigliuolo, G. M., D’Amato, A., & Arnoldi, A. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf500795b · Cited by 115

Biosynthesis of Mevalonic Acid from Acetyl-CoA

Bochar, D. A., Freisen, J., Stauffacher, C. V., & Rodwell, V. W. (1999) · Elsevier eBooks · doi:10.1016/b978-0-08-091283-7.00035-7 · Cited by 109

Camphene, a Plant-Derived Monoterpene, Reduces Plasma Cholesterol and Triglycerides in Hyperlipidemic Rats Independently of HMG-CoA Reductase Activity

Vallianou, I., Peroulis, N., Pantazis, P., & Hadzopoulou‐Cladaras, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020516 · Cited by 108

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor

Bischoff, H., Angerbauer, R., Bender, J., Bischoff, E., Faggiotto, A., Petzinna, D., Pfitzner, J., Porter, M. C., Schmidt, D. D., & Thomas, G. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00188-3 · Cited by 108

Inhibition of Growth of Methane-Producing Bacteria of the Ruminant Forestomach by Hydroxymethylglutaryl∼SCoA Reductase Inhibitors

Miller, T. L., & Wolin, M. J. (2001) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(01)70177-4 · Cited by 107

Statins: the new aspirin?

Veillard, N. R., & Mach, F. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012505 · Cited by 107

The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins

Murphy, C., Deplazes, E., Cranfield, C. G., & Garcia, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228745 · Cited by 119

Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan

Mabuchi, H. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16008 · Cited by 102

Lowering Low-Density Lipoprotein Cholesterol: Statins, Ezetimibe, Bile Acid Sequestrants, and Combinations: Comparative Efficacy and Safety

Hou, R., & Goldberg, A. C. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.007 · Cited by 100

Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages

Namatame, I., Tomoda, H., Ishibashi, S., & Ōmura, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307757100 · Cited by 96

Cardiovascular risk scores do not account for the effect of treatment: a review

Liew, S. M., Doust, J. A., & Glasziou, P. (2011) · Heart · doi:10.1136/hrt.2010.220442 · Cited by 95

Single-molecule theory of enzymatic inhibition

Robin, T., Reuveni, S., & Urbakh, M. (2018) · Nature Communications · doi:10.1038/s41467-018-02995-6 · Cited by 99

Cardiology's 10 greatest discoveries of the 20th century.

Mehta, N. J., & Khan, I. A. (2002) · Europe PMC (PubMed Central) · Cited by 94

Pathways to Biomedical Discovery

Thagard, P. R. (2003) · Philosophy of Science · doi:10.1086/375465 · Cited by 93

ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin

Kajinami, K., Brousseau, M. E., Nartsupha, C., Ordovás, J. M., & Schaefer, E. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300278-jlr200 · Cited by 92

Statins: Then and Now

Toth, P. P., & Banach, M. (2019) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-15-1-23 · Cited by 99

Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice

Kosters, A., Frijters, R., Schaap, F. G., Vink, E., Plösch, T., Ottenhoff, R., Jirsa, M., Cuyper, I. M. D., Kuipers, F., & Groen, A. K. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00093-x · Cited by 92

Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management

Kajinami, K., Takekoshi, N., Brousseau, M. E., & Schaefer, E. J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.09.004 · Cited by 92

Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic

Lencz, T., & Malhotra, A. K. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.28 · Cited by 87

Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia

Naoumova, R. P., Marais, A. D., Mountney, J., Firth, J. C., Rendell, N. B., Taylor, G. W., & Thompson, G. R. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05649-1 · Cited by 89

Effects of Cholesterol-Lowering Statins on the Aqueous Humor Outflow Pathway

Song, J., Deng, P., Stinnett, S. S., Epstein, D. L., & Rao, P. V. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0776 · Cited by 88

The biosynthesis of steroids and triterpenoids

Brown, G. D. (1998) · Natural Product Reports · doi:10.1039/a815653y · Cited by 90

Mechanisms of Action and Efficacy of Statins against Influenza

Mehrbod, P., Omar, A. R., Bejo, M. H., Haghani, A., & Ideris, A. (2014) · BioMed Research International · doi:10.1155/2014/872370 · Cited by 87

Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition

Kim, H., Oh, G. T., Park, Y. B., Lee, M., Seo, H., & Choi, M. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.08.026 · Cited by 87

Crystal Structure of Pseudomonas mevalonii HMG-CoA Reductase at 3.0 Angstrom Resolution

Lawrence, C. M., Rodwell, V. W., & Stauffacher, C. V. (1995) · Science · doi:10.1126/science.7792601 · Cited by 87

Farnesol signalling in Candida albicans – more than just communication

Polke, M., Leonhardt, I., Kurzai, O., & Jacobsen, I. D. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1337711 · Cited by 92

The Hepatitis Delta Virus Large Antigen Is Farnesylated Both in Vitro and in Animal Cells

Otto, J. C., & Casey, P. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.4569 · Cited by 86

Direct Effects of Statins on the Vascular Wall

Corsini, A., Pazzucconi, F., Arnaboldi, L., Pfister, P., Fumagalli, R., Paoletti, R., & Sirtori, C. R. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199805000-00017 · Cited by 86

Cholesterol-Lowering Drugs and Incident Open-Angle Glaucoma: A Population-Based Cohort Study

Marcus, M. W., Müskens, R. P. H. M., Ramdas, W. D., Wolfs, R. C. W., de Jong, P. T. V. M., Vingerling, J. R., Albert Hofman, D., Stricker, B. H. C., & Jansonius, N. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029724 · Cited by 85

Reducing shell egg cholesterol content. I. Overview, genetic approaches, and nutritional strategies

Elkin, R. G. (2006) · World s Poultry Science Journal · doi:10.1017/s0043933906001206 · Cited by 88

Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl–CoA reductase

Tabernero, L., Bochar, D. A., Rodwell, V. W., & Stauffacher, C. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7167 · Cited by 85

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

Tobert, J. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1112 · Cited by 896

HMG-CoA reductase inhibitors as potent cholesterol lowering drugs

Tsujita, Y. (1994) · Gordon and Breach Science Publishers eBooks · Cited by 2

Lipid-lowering drugs: discovery and development of HMG-CoA reductase inhibitors.

Tsujita, Y. (1995) · 生体の科学

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760

The discovery of the HMG-CoA reductase inhibitors “statins”: A historical perspective

Endo, A. (2001) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.28.6_111